Instiute of Intelligent Control and Robotics, Hangzhou Dianzi University, Hangzhou, China.
Department of Radiation Oncology, Zhejiang Hospital, Hangzhou, China.
J Appl Clin Med Phys. 2023 Aug;24(8):e13998. doi: 10.1002/acm2.13998. Epub 2023 Apr 22.
We retrospectively studied the dosimetry and setup accuracy of deep inspiration breath-hold (DIBH) radiotherapy in right-sided breast cancer patients with regional nodal irradiation (RNI) who had completed treatment based on surface-guided radiotherapy (SGRT) technology by Sentinel/Catalyst system, aiming to clarify the clinical application value and related issues.
Dosimetric indicators of four organs at risk (OARs), namely the heart, right coronary artery (RCA), right lung, and liver, were compared on the premise that the planning target volume met dose-volume prescription requirements. Meanwhile, the patients were divided into the edge of the xiphoid process (EXP), sternum middle (SM), and left breast wall (LBW) groups according to different positions of respiratory gating primary points. The CBCT setup error data of the three groups were contrasted for the treatment accuracy study, and the effects of different gating window heights on the right lung volume increases were compared among the three groups.
Compared with free breath (FB), DIBH reduced the maximum dose of heart and RCA by 739.3 ± 571.2 cGy and 509.8 ± 403.8 cGy, respectively (p < 0.05). The liver changed the most in terms of the mean dose (916.9 ± 318.9 cGy to 281.2 ± 150.3 cGy, p < 0.05). The setup error of the EXP group in the anterior-posterior (AP) direction was 3.6 ± 4.5 mm, which is the highest among the three groups. The right lung volume increases in the EXP, SM, and LBW groups were 72.3%, 69.9%, and 67.2%, respectively (p = 0.08), and the corresponding breath-holding heights were 13.5 ± 3.7 mm, 10.3 ± 2.4 mm, and 9.6 ± 2.8 mm, respectively (p < 0.05).
SGRT-based DIBH radiotherapy can better protect the four OARs of right-sided breast cancer patients with RNI. Different respiratory gating primary points have different setup accuracy and breath-hold height.
我们回顾性研究了基于 Sentinel/Catalyst 系统表面引导放疗(SGRT)技术完成治疗的右侧乳腺癌伴区域淋巴结照射(RNI)患者深吸气屏气(DIBH)放疗的剂量学和摆位精度,旨在阐明其临床应用价值和相关问题。
在满足计划靶区剂量-体积要求的前提下,比较了四个危及器官(OAR)即心脏、右冠状动脉(RCA)、右肺和肝脏的剂量学指标。同时,根据呼吸门控起点的不同位置,将患者分为剑突边缘(EXP)、胸骨中段(SM)和左乳房壁(LBW)组。对比三组的锥形束 CT(CBCT)摆位误差数据,研究治疗精度,并比较三组不同门控窗高度对右肺体积增加的影响。
与自由呼吸(FB)相比,DIBH 使心脏和 RCA 的最大剂量分别降低了 739.3±571.2 cGy 和 509.8±403.8 cGy(p<0.05)。肝脏的平均剂量变化最大(从 916.9±318.9 cGy 变为 281.2±150.3 cGy,p<0.05)。EXP 组在前后(AP)方向的摆位误差为 3.6±4.5mm,为三组中最高。EXP、SM 和 LBW 组的右肺体积增加分别为 72.3%、69.9%和 67.2%(p=0.08),相应的屏气高度分别为 13.5±3.7mm、10.3±2.4mm 和 9.6±2.8mm(p<0.05)。
基于 SGRT 的 DIBH 放疗可更好地保护右侧乳腺癌伴 RNI 患者的四个 OAR。不同的呼吸门控起点有不同的摆位精度和屏气高度。